Despite intensive long-term efforts, with very few exceptions, the development of effective vaccines against parasitic infections has presented considerable challenges, given the …
TM Silva, M Estrela, V Roque, ER Gomes… - Age and …, 2022 - academic.oup.com
Abstract Background Coronavirus 2019 (COVID-19) has become a public-health emergency of international concern. Most efforts to contain the spread and transmission of the virus rely …
H Lei, A Alu, J Yang, W Ren, C He, T Lan… - … and Targeted Therapy, 2022 - nature.com
The outbreak of coronavirus disease 2019 (COVID-19) has posed great threats to global health and economy. Several effective vaccines are available now, but additional booster …
G Marfe, S Perna, AK Shukla - Experimental and …, 2021 - spandidos-publications.com
At the end of 2019, a new disease recognized such as severe acute respiratory syndrome (SARS), was reported in Wuhan, China. This disease was caused by an unknown SARS …
I Papagiouvanni, SC Kotoulas, A Pataka… - World Journal of …, 2023 - ncbi.nlm.nih.gov
The new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified in December 2019, in Wuhan, China. The virus was rapidly spread worldwide …
Severe acute respiratory syndrome coronavirus (SARS‐CoV), Middle East respiratory syndrome coronavirus (MERS‐CoV), and the current severe acute respiratory syndrome …
J Huang, Y Ding, J Yao, M Zhang, Y Zhang, Z Xie… - Vaccines, 2022 - mdpi.com
COVID-19 is still prevalent around the globe. Although some SARS-CoV-2 vaccines have been distributed to the population, the shortcomings of vaccines and the continuous …
W Xu, W Ren, T Wu, Q Wang, M Luo, Y Yi, J Li - Vaccines, 2023 - mdpi.com
With the mass vaccination program for COVID-19 mRNA vaccines, there has been sufficient real-world study (RWS) on the topic to summarize their safety in the total population and in …
Background Information on neurological and psychiatric adverse events following immunization (AEFIs) with COVID-19 vaccines is limited. Research design & methods We …